2-[(2E)-2-[(4-ethylphenyl)methylidene]-3-oxo-1,4-benzothiazin-4-yl]-N-[(1S,2R)-2-methylcyclohexyl]acetamide

C26H30N2O2S — CID 92657385

IUPAC2-[(2E)-2-[(4-ethylphenyl)methylidene]-3-oxo-1,4-benzothiazin-4-yl]-N-[(1S,2R)-2-methylcyclohexyl]acetamide
SMILESCCc1ccc(/C=C2/Sc3ccccc3N(CC(=O)N[C@H]3CCCC[C@H]3C)C2=O)cc1
InChIInChI=1S/C26H30N2O2S/c1-3-19-12-14-20(15-13-19)16-24-26(30)28(22-10-6-7-11-23(22)31-24)17-25(29)27-21-9-5-4-8-18(21)2/h6-7,10-16,18,21H,3-5,8-9,17H2,1-2H3,(H,27,29)/b24-16+/t18-,21+/m1/s1
InChIKeyYNZUHQZVVOGLKQ-LWTMIWEOSA-N
MW434.61 g/mol
LogP5.42
Rot. Bonds5

About 2-[(2E)-2-[(4-ethylphenyl)methylidene]-3-oxo-1,4-benzothiazin-4-yl]-N-[(1S,2R)-2-methylcyclohexyl]acetamide

2-[(2E)-2-[(4-ethylphenyl)methylidene]-3-oxo-1,4-benzothiazin-4-yl]-N-[(1S,2R)-2-methylcyclohexyl]acetamide (PubChem CID 92657385) has the molecular formula C26H30N2O2S and a molecular weight of 434.61 g/mol. Its IUPAC name is 2-[(2E)-2-[(4-ethylphenyl)methylidene]-3-oxo-1,4-benzothiazin-4-yl]-N-[(1S,2R)-2-methylcyclohexyl]acetamide.

Molecular Properties

Compound Name2-[(2E)-2-[(4-ethylphenyl)methylidene]-3-oxo-1,4-benzothiazin-4-yl]-N-[(1S,2R)-2-methylcyclohexyl]acetamide
PubChem CID92657385
Molecular FormulaC26H30N2O2S
Molecular Weight434.61 g/mol
Exact Mass434.20
IUPAC Name2-[(2E)-2-[(4-ethylphenyl)methylidene]-3-oxo-1,4-benzothiazin-4-yl]-N-[(1S,2R)-2-methylcyclohexyl]acetamide
SMILESCCc1ccc(/C=C2/Sc3ccccc3N(CC(=O)N[C@H]3CCCC[C@H]3C)C2=O)cc1
InChIInChI=1S/C26H30N2O2S/c1-3-19-12-14-20(15-13-19)16-24-26(30)28(22-10-6-7-11-23(22)31-24)17-25(29)27-21-9-5-4-8-18(21)2/h6-7,10-16,18,21H,3-5,8-9,17H2,1-2H3,(H,27,29)/b24-16+/t18-,21+/m1/s1
InChIKeyYNZUHQZVVOGLKQ-LWTMIWEOSA-N
XLogP5.42
TPSA49.41 Ų
H-Bond Donors1
H-Bond Acceptors3
Rotatable Bonds5
Heavy Atoms31
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500434.61
LogP ≤ 55.42
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 103

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze 2-[(2E)-2-[(4-ethylphenyl)methylidene]-3-oxo-1,4-benzothiazin-4-yl]-N-[(1S,2R)-2-methylcyclohexyl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[(2E)-2-[(4-ethylphenyl)methylidene]-3-oxo-1,4-benzothiazin-4-yl]-N-[(1S,2R)-2-methylcyclohexyl]acetamide?
The IUPAC name of 2-[(2E)-2-[(4-ethylphenyl)methylidene]-3-oxo-1,4-benzothiazin-4-yl]-N-[(1S,2R)-2-methylcyclohexyl]acetamide (CID 92657385) is 2-[(2E)-2-[(4-ethylphenyl)methylidene]-3-oxo-1,4-benzothiazin-4-yl]-N-[(1S,2R)-2-methylcyclohexyl]acetamide.
What is the SMILES notation for 2-[(2E)-2-[(4-ethylphenyl)methylidene]-3-oxo-1,4-benzothiazin-4-yl]-N-[(1S,2R)-2-methylcyclohexyl]acetamide?
The canonical SMILES for 2-[(2E)-2-[(4-ethylphenyl)methylidene]-3-oxo-1,4-benzothiazin-4-yl]-N-[(1S,2R)-2-methylcyclohexyl]acetamide is CCc1ccc(/C=C2/Sc3ccccc3N(CC(=O)N[C@H]3CCCC[C@H]3C)C2=O)cc1.
What is the InChIKey of 2-[(2E)-2-[(4-ethylphenyl)methylidene]-3-oxo-1,4-benzothiazin-4-yl]-N-[(1S,2R)-2-methylcyclohexyl]acetamide?
The InChIKey is YNZUHQZVVOGLKQ-LWTMIWEOSA-N. The full InChI is InChI=1S/C26H30N2O2S/c1-3-19-12-14-20(15-13-19)16-24-26(30)28(22-10-6-7-11-23(22)31-24)17-25(29)27-21-9-5-4-8-18(21)2/h6-7,10-16,18,21H,3-5,8-9,17H2,1-2H3,(H,27,29)/b24-16+/t18-,21+/m1/s1.
What are the key properties of 2-[(2E)-2-[(4-ethylphenyl)methylidene]-3-oxo-1,4-benzothiazin-4-yl]-N-[(1S,2R)-2-methylcyclohexyl]acetamide?
2-[(2E)-2-[(4-ethylphenyl)methylidene]-3-oxo-1,4-benzothiazin-4-yl]-N-[(1S,2R)-2-methylcyclohexyl]acetamide has a molecular weight of 434.61 g/mol, XLogP of 5.42, 5 rotatable bonds, 1 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(2E)-2-[(4-ethylphenyl)methylidene]-3-oxo-1,4-benzothiazin-4-yl]-N-[(1S,2R)-2-methylcyclohexyl]acetamide is sourced from PubChem (CID 92657385), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).